Core Director: Rui-Ming Liu, Ph.D. Idiopathic pulmonary fibrosis (IPF) is a most enigmatic fatal lung disorder. Although significant progress has been made in our understanding of IPF pathogenesis, ...
Significant research funding in the form of a five-year, $12.1 million U19 Grant from the National Institutes of Health (NIH) has been awarded to a collaboration of research teams co-led by ...
Renovaro Inc. announces funding approval for LUMINA, a platform detecting minimal residual disease in lung cancer using multi-omics and AI. Renovaro Inc. announced that its subsidiary, RenovaroCube, ...
Public Health Relevance Statement: Idiopathic Pulmonary Fibrosis (IPF) is fatal lung disorder for which no U.S. FDA-approved drugs currently exist. This project will lead to the development of novel ...
"Lung cancer remains a devastating disease, and Prof. Yarden's approach to tackling drug resistance with bispecific antibodies is precisely the kind of bold, out-of-the-box science that can transform ...
SEOUL, South Korea, Nov. 11, 2025 /PRNewswire/ -- Coreline Soft, a global leader in AI-powered chest diagnostic solutions, today announced its selection as the exclusive artificial intelligence ...